![]() |
市場調査レポート
商品コード
1753880
核酸分離・精製市場レポート:製品別、タイプ別、方法別、エンドユーザー別、地域別、2025~2033年Nucleic Acid Isolation and Purification Market Report by Product, Type, Method, End User, and Region 2025-2033 |
||||||
カスタマイズ可能
|
核酸分離・精製市場レポート:製品別、タイプ別、方法別、エンドユーザー別、地域別、2025~2033年 |
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 146 Pages
納期: 2~3営業日
|
世界の核酸分離・精製の市場規模は2024年に57億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに105億米ドルに達し、2025~2033年にかけて7.1%の成長率(CAGR)を示すと予測しています。分子診断および研究における需要の増加、自動化とハイスループット技術の進歩、COVID-19パンデミックの影響、ヘルスケア以外の用途の拡大などが市場を推進する主な要因です。
核酸分離・精製は、さまざまな生物学的サンプルからデオキシリボ核酸(DNA)またはリボ核酸(RNA)分子を分離・精製する際に採用されるプロセスを指します。分子生物学や診断学において重要な工程です。サンプルは通常、分離の段階で溶解され、核酸が遊離されます。その後、ポリメラーゼ連鎖反応(PCR)、配列決定、分析などの下流工程に適した純粋な核酸を得るために、夾雑物、タンパク質、その他の細胞成分を除去する精製が行われます。フェノール-クロロホルム抽出、カラムクロマトグラフィー、磁気ビーズを用いた方法などが一般的に用いられています。
世界の核酸分離・精製市場は、ヘルスケア、バイオテクノロジー、製薬など様々な分野における分子診断や遺伝子研究の需要の高まりによって力強い成長を遂げています。これに伴い、個別化医療やゲノミクス研究の重要性が高まり続ける中、効率的な核酸分離・精製技術へのニーズが急増しており、市場拡大への明るい展望が生まれています。さらに、自動化とハイスループット技術の大幅な進歩により、これらのプロセスが合理化され、手作業が減り、効率が向上し、それによって市場の成長が促進されています。これに加えて、COVID-19の大流行により、PCRベースの検査が広く使用されるようになったため、核酸分離・精製製品に対する需要が高まり、市場拡大の一助となっています。さらに、製品性能の向上と応用分野の拡大を目的とした市場各社の研究開発(R&D)投資の増加が、市場の成長に寄与しています。
分子診断と遺伝子研究に対する需要の増加
核酸分離・精製市場を牽引する主な要因の1つは、分子診断と遺伝子研究の需要拡大です。ヘルスケア分野では、遺伝子情報を利用して個々の患者に合った治療を行う個別化医療が重視されるようになっています。この動向は、効率的で正確な核酸分離・精製法の必要性に拍車をかけています。これと同時に、研究者や臨床医は、PCR、シーケンシング、遺伝子発現解析などの様々な分子検査を行うために、高品質のDNAやRNAサンプルを必要としています。同様に、バイオテクノロジーや製薬業界は、新薬、ワクチン、治療法の開発や試験に核酸分離・精製を大いに活用しています。このような複数の分野にわたる持続的な需要が、市場成長の主要な原動力となっています。
自動化とハイスループット技術の進歩
核酸分離・精製プロセスにおける自動化と高スループット技術の継続的な進歩も、市場成長を後押しする重要な要因です。自動化システムとロボットプラットフォームは、これらの手順を合理化・標準化し、手作業への依存を減らし、汚染のリスクを最小限に抑えるために開発されてきました。これに伴い、ハイスループット機器や手法により、研究者はより多くのサンプルを同時に処理できるようになり、効率性と拡張性が向上しました。このような技術革新は時間を節約し、再現性と一貫性を高めるため、より高いスループットと精度の向上を求める研究室や研究施設にとってますます魅力的なものとなっています。
COVID-19パンデミックの影響
COVID-19パンデミックは、核酸分離・精製業界に大きな影響を及ぼしました。COVID-19の診断に欠かせないPCRベースの検査は、ウイルスRNAの単離と精製に大きく依存しています。COVID-19検査の需要の急増は、研究・サーベイランスの必要性と共に、核酸分離・精製製品の利用をかつてないほど増加させました。市場プレーヤーは、生産規模を拡大し、SARS-CoV-2検出用に特化したキットや試薬を開発することで、この需要に迅速に対応しました。パンデミックの動態は時間の経過とともに変化する可能性がありますが、感染症対策や研究における強固な核酸分離・精製プロセスの重要性に対する意識の高まりは、市場の成長に永続的な影響を与えると予想されます。
The global nucleic acid isolation and purification market size reached USD 5.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 10.5 Billion by 2033, exhibiting a growth rate (CAGR) of 7.1% during 2025-2033. The increasing demand in molecular diagnostics and research, automation and high-throughput technology advancements, the impact of the COVID-19 pandemic, and expanding applications beyond healthcare are some of the major factors propelling the market.
Nucleic acid isolation and purification refers to the processes employed in separating and refining deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) molecules from various biological samples. This essential step is crucial in molecular biology and diagnostics. The sample is typically lysed in the isolation phase to release nucleic acids. Subsequently, purification involves removing contaminants, proteins, and other cellular components to yield pure nucleic acids suitable for downstream applications, including polymerase chain reaction (PCR), sequencing, or analysis. Techniques such as phenol-chloroform extraction, column chromatography, or magnetic bead-based methods are commonly used.
The global nucleic acid isolation and purification market is experiencing robust growth driven by the increasing demand for molecular diagnostics and genetic research across various fields, including healthcare, biotechnology, and pharmaceuticals. In line with this, as the importance of personalized medicine and genomics research continues to rise, there is a surging need for efficient nucleic acid isolation and purification techniques, creating a positive outlook for market expansion. Moreover, significant advancements in automation and high-throughput technologies have streamlined these processes, reducing manual labor and improving efficiency, thereby fostering market growth. In addition to this, the COVID-19 pandemic has impelled the demand for nucleic acid isolation and purification products due to the extensive use of PCR-based testing, thereby aiding in market expansion. Furthermore, rising investments in research and development (R&D) by market players to enhance product performance and expand application areas are contributing to the market's growth.
Increasing demand for molecular diagnostics and genetic research
One of the primary factors driving the nucleic acid isolation and purification market is the growing demand for molecular diagnostics and genetic research. In the healthcare sector, there is a rising emphasis on personalized medicine, where genetic information is used to tailor treatments to individual patients. This trend has spurred the need for efficient and accurate nucleic acid isolation and purification methods. Concurrent with this, researchers and clinicians require high-quality DNA and RNA samples to perform various molecular tests, including PCR, sequencing, and gene expression analysis. Similarly, the biotechnology and pharmaceutical industries heavily rely on nucleic acid isolation and purification to develop and test new drugs, vaccines, and therapies. This sustained demand across multiple sectors is a key driving force behind the market's growth.
Advancements in automation and high-throughput technologies
Another significant factor fueling market growth is the continuous advancement of automation and high-throughput technologies in nucleic acid isolation and purification processes. Automation systems and robotic platforms have been developed to streamline and standardize these procedures, reducing the dependence on manual labor and minimizing the risk of contamination. In line with this, High-throughput instruments and methods enable researchers to process a larger number of samples simultaneously, improving efficiency and scalability. These technological innovations save time and enhance the reproducibility and consistency of nucleic acid isolation and purification, making them increasingly attractive to laboratories and research facilities seeking higher throughput and improved precision.
Impact of the COVID-19 pandemic
The ongoing COVID-19 pandemic has exerted a significant influence on the nucleic acid isolation and purification industry. PCR-based testing, a crucial tool for diagnosing COVID-19, relies heavily on the isolation and purification of viral RNA. The surge in demand for COVID-19 testing, along with the need for research and surveillance, has led to an unprecedented uptick in the utilization of nucleic acid isolation and purification products. Market players quickly adapted to meet this demand by scaling up production and developing specialized kits and reagents for SARS-CoV-2 detection. Although the pandemic's dynamics may change over time, the heightened awareness of the importance of robust nucleic acid isolation and purification processes in infectious disease control and research is expected to have a lasting impact on the market's growth.
Kits and reagents dominate the market
The demand for nucleic acid isolation and purification products, specifically kits and reagents, is propelled by the expanding application of nucleic acid-based techniques in the fields of forensic science and environmental monitoring. These areas increasingly rely on nucleic acid isolation and purification for DNA profiling, crime scene analysis, and identifying microbial contaminants. Additionally, the growing interest in agriculture and food safety drives the need for genetic testing and traceability, spurring demand for nucleic acid products. Apart from this, the emergence of innovative and specialized kits and reagents tailored to specific applications, such as RNA sequencing or viral RNA extraction, is attracting researchers and diagnostic labs, strengthening the market growth. Furthermore, the continuous development of user-friendly, cost-effective, and high-performance products accelerate the utilization of nucleic acid isolation and purification kits and reagents across various industries, providing impetus to the market growth.
Plasmid DNA isolation and purification holds the largest share in the market
The increasing importance of plasmid DNA in biotechnology and gene therapy applications is driving the demand for plasmid DNA isolation and purification. Plasmids are vital tools for genetic engineering, gene expression, and recombinant protein production, making them indispensable in the biopharmaceutical industry. Moreover, the rise of gene and cell therapies has created a surge in the demand for high-quality plasmid DNA for vector construction and therapeutic gene delivery, aiding in market expansion. Concurrent with this, the expanding field of synthetic biology, where custom-designed plasmids are employed to create novel biological systems, fuels the need for efficient plasmid DNA isolation and purification methods. The development of advanced purification techniques, such as chromatography and membrane-based systems, further enhances the purity and yield of plasmid DNA, making them essential components in the biotechnology and medical sectors and driving market demand.
Column-based isolation and purification dominates the market
The demand for nucleic acid isolation and purification, specifically through column-based methods, is fueled by the preference for column-based techniques in research and clinical laboratories due to their efficiency, simplicity, and scalability. These methods offer researchers a reliable and convenient means of isolating and purifying nucleic acids with high purity and yield. Additionally, the versatility of column-based systems enables their use across a wide range of applications, from fundamental research to diagnostics, impelling the market growth. Moreover, advancements in column technology, such as improved matrix materials and design, have led to enhanced performance and faster processing times, making them increasingly attractive to users seeking rapid and consistent results. Furthermore, the stringent quality control requirements in genomics, molecular diagnostics, and pharmaceuticals have led to the continued adoption of column-based nucleic acid isolation and purification methods, driving sustained demand in the market.
Hospitals and diagnostic centers hold the largest share in the market
The demand for nucleic acid isolation and purification products, particularly among hospital and diagnostic end-users, is primarily driven by the growing significance of molecular diagnostics in healthcare. Hospitals and diagnostic laboratories increasingly rely on nucleic acid-based tests to accurately diagnose various diseases, including infectious diseases, cancer, and genetic disorders. This has resulted in a consistent demand for high-quality DNA and RNA samples, thus fueling the need for efficient nucleic acid isolation and purification methods. Additionally, the rapid adoption of point-of-care testing and the emergence of novel diagnostic assays have amplified the demand for streamlined nucleic acid extraction processes that can be integrated into diagnostic workflows, thereby bolstering the market growth. As precision medicine gains prominence in patient care, hospitals are also utilizing nucleic acid purification techniques for personalized treatment strategies, propelling the market forward.
North America exhibits a clear dominance, accounting for the largest nucleic acid isolation and purification market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America's well-established and advanced healthcare infrastructure, along with a robust presence of pharmaceutical and biotechnology companies, has created a significant demand for nucleic acid isolation and purification products. As precision medicine and genetic research gain momentum, the need for high-quality DNA and RNA samples in North America continues to rise, driving the market's growth. In addition to this, the increasing prevalence of chronic conditions such as cancer, infectious diseases, and genetic disorders in the region has led to an elevated demand for molecular diagnostics, further boosting the requirement for efficient nucleic acid isolation and purification methods. Furthermore, North America has been at the forefront of research and development in genomics, gene therapy, and biopharmaceuticals, contributing to the adoption of advanced purification techniques and specialized kits and reagents, thus playing a pivotal role in driving market expansion in the region.
The competitive landscape of the global nucleic acid isolation and purification market is characterized by intense rivalry among key players and a dynamic ecosystem of companies providing an array of products and services. Prominent companies dominate the market with their extensive product portfolios, global reach, and continuous investments in research and development. Additionally, a multitude of smaller and niche players cater to specialized segments and applications within the market, providing innovative solutions and fostering competition. Collaborations and partnerships between market players and research institutions are commonplace, further intensifying competition and driving innovation. As the market continues to expand, new entrants are attracted to its potential, contributing to a dynamic competitive landscape.